Heparin strongly induces soluble fms-Like tyrosine kinase 1 release in vivo and in vitro: brief report
Searle, Julia, Mockel, Martin, Gwosc, Stefanie, Datwyler, Saul A., Fatimunnisa, Qadri, Albert, Gesa I., Holert, Fabian, Isbruch, Annette, Klug, Lars, Muller, Dominik N., Dechend, Ralf, Muller, Reinhold, Vollert, Joern O., Slagman, Anna, Mueller, Christian, and Herse, Florian (2011) Heparin strongly induces soluble fms-Like tyrosine kinase 1 release in vivo and in vitro: brief report. Arteriosclerosis, Thrombosis and Vascular Biology, 31 (12). pp. 2972-2974.
|PDF (Published Version) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://dx.doi.org/10.1161/ATVBAHA.111.23...
Objective: Soluble fms-like tyrosine kinase 1 (sFlt1) is involved in the pathophysiology of preeclampsia and coronary artery disease. Because sFlt1 has a heparin-binding site, we investigated whether or not heparin releases sFlt1 from the extracellular matrix.
Methods and Results: We measured sFlt1 before and after heparin administration in 135 patients undergoing coronary angiography, percutanous coronary intervention, or both. sFlt1 was increased directly after heparin administration (from 254 to 13 440 pg/mL) and returned to baseline within 10 hours. Umbilical veins and endothelial cells treated with heparin released sFlt1. Heparinase I and III also increased sFlt1. Mice treated with heparin had elevated sFlt1 serum levels. Their serum inhibited endothelial tube formation.
Conclusion: Heparin releases sFlt1 by displacing the sFlt1 heparin-binding site from heparan sulfate proteoglycans. Heparin could induce an antiangiogenic state.
|Item Type:||Article (Refereed Research - C1)|
|Keywords:||angiogenesis, angiography, coronary artery disease, heparin, sFlt1|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111799 Public Health and Health Services not elsewhere classified @ 100%|
|SEO Codes:||92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920199 Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified @ 100%|
|Deposited On:||05 Apr 2012 14:11|
|Last Modified:||18 Oct 2013 01:29|
Last 12 Months: 0
|Citation Counts with External Providers:|
Repository Staff Only: item control page